Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by platelet count less than 100×10(9)/L and an increased risk of bleeding. The risk of bleeding increases in proportion with the degree of thrombocytopenia. Although several medications are used for primary thrombocytopenia treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidika, Erjola, Fayyaz, Hafsa, Salib, Marina, Memon, Areeba N, Gowda, Asavari S, Rallabhandi, Bhavana, Cancarevic, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505620/
https://www.ncbi.nlm.nih.gov/pubmed/32968581
http://dx.doi.org/10.7759/cureus.9920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505620/
https://www.ncbi.nlm.nih.gov/pubmed/32968581
http://dx.doi.org/10.7759/cureus.9920

Ejemplares similares